Inhaled Iloprost for Suspected COVID-19 Respiratory Failure
Clinical trial NCT04445246 · COMPLETED
Trial details
- NCT number
- NCT04445246
- Sponsor
- Hamad Medical Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-23
- Primary completion
- 2021-05-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.